SLC6A3 and Parkinsonism: In particular, 123 I-FP-CIT-DAT-SPECT has been applied in a large number of trials in order to identify in vivo the loss of dopamine transporters in the striatum of patients with presynaptic parkinsonism [182,183,184,185,186].